Home / Business and Economy / Thyrocare Founder's New Mission: Disrupting Dentistry
Thyrocare Founder's New Mission: Disrupting Dentistry
11 Feb
Summary
- Velumani aims to disrupt dentistry, similar to his Thyrocare success.
- AVM Smiles plans 1,000 dental outlets by 2030.
- He focuses on inefficiencies, like empty dental chairs, for opportunity.
A. Velumani, renowned for building Thyrocare into a leading diagnostics chain, has embarked on a new entrepreneurial journey with AVM Smiles, a national dental platform. He is applying his disruption thesis to the dentistry sector, aiming to address market inefficiencies.
Velumani's strategy for AVM Smiles mirrors his past success: simplifying operations, specializing services, and scaling through a franchise model. The venture seeks to optimize dental clinic utilization, with a goal of establishing 1,000 outlets by 2030.
Unlike his previous venture, Velumani is entering a more established market. However, he identifies significant inefficiencies, such as underutilized dental chairs, as opportunities for disruption. His focus remains on efficiency and affordability, seeking to create scalable systems.
AVM Smiles is structured as a franchise-owned, franchise-operated model, contrasting with the company-owned approach of its founders' previous clinics. Velumani's role is that of an operating mentor, providing expertise in cost discipline, procurement, and strategy, rather than direct capital investment.
This initiative signifies Velumani's return to hands-on entrepreneurship after a successful exit from Thyrocare. He continues to advocate for capital discipline and operational efficiency, applying these principles to disrupt areas he believes are ripe for innovation.
